Contribution of hypertension and other risk factors to survival and mortality in the Russian population

Author:

Balanova Yu. A.1ORCID,Shalnova S. A.1ORCID,Kutsenko V. A.2ORCID,Imaeva A. E.1ORCID,Kapustina A. V.1ORCID,Muromtseva G. A.1ORCID,Evstifeeva S. E.1ORCID,Maksimov S. A.1ORCID,Karamnova N. S.1ORCID,Yarovaya E. B.2ORCID,Kulakova N. V.3ORCID,Kalachikova O. N.4ORCID,Chernykh T. M.5ORCID,Belova O. A.6ORCID,Artamonova G. V.7ORCID,Indukaeva E. V.7ORCID,Grinshtein Yu. I.8ORCID,Libis R. A.9ORCID,Duplyakov D. V.10ORCID,Rotar O. P.11ORCID,Trubacheva I. A.12ORCID,Serebryakova V. N.12ORCID,Efanov A. Yu.13ORCID,Konradi A. O.11ORCID,Boytsov S. A.14ORCID,Drapkina O. M.1ORCID

Affiliation:

1. National Medical Research Center for Therapy and Preventive Medicine

2. National Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State University

3. Pacific State Medical University

4. Vologda Research Center

5. N.N. Burdenko Voronezh State Medical University

6. Cardiology dispensary

7. Research Institute for Complex Issues of Cardiovascular Diseases

8. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

9. Orenburg State Medical University

10. Research Institute of Cardiology, Samara State Medical University

11. Almazov National Medical Research Center

12. Cardiology Research Institute, Tomsk National Research Medical Center

13. Tyumen State Medical University

14. National Medical Research Center of Cardiology

Abstract

Aim. To study the contribution of hypertension (HTN) to survival and mortality in the Russian population.Material and methods. This prospective observational cohort included representative samples from 11 Russian regions (men and women aged 25-64 years, n=18251) examined in 2012-2014 as part of the Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. The examination included a questionnaire (12 modules), anthropometric and blood pressure (BP) measurements, as well as biochemical blood tests. HTN was considered aa a systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg, or when a subject receives antihypertensives. Treatment efficacy was considered as the proportion of persons (%) who achieved target BP among those taking antihypertensives. Depending on HTN status, all participants were divided into 4 groups: 1) those without HTN;2)        those with HTN, taking antihypertensive agents and having systolic BP ≤140 mm H. and diastolic BP ≤90 mm Hg (effective therapy);3)        those with HTN, taking medications, but not achieving target BP (ineffective therapy); 4) those with HTN, not taking antihypertensives. The life status of participants was updated every 2 years. Kaplan-Meier survival curves, as well as univariate and multivariate Cox proportional hazards models were created.Results. The presence of HTN significantly reduced survival (p<0,001) in the cohort, which is significant when adjusted for age (men — relative risk (RR)=1,47, p<0,001, women — RR=1,17, p<0,001). In the multivariate model, the male sex (RR=2,3 p<0,001), age increase, smoking, tachycardia, and HTN are significant for all-cause mortality only for men, but not for women. However, for women, absence of higher education was significant. The presence of HTN significantly worsens cardiovascular survival in both sexes (p<0,0001). HTN increases the risk of a composite endpoint for both men and women (p<0,001). Analysis of Kaplan-Meier curves showed the worst survival rate in persons with HTN, taking antihypertensive drugs, but not reaching target BP levels.Conclusion. The presence of HTN significantly worsens the survival rate of men and women. Special attention of medical community should be directed to increasing the proportion of effectively treated patients with HTN.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Shalnova SA, Deev AD, Balanova YuA, et al. Twenty years trends of obesity and arterial hypertension and their association in Russia. Cardiovascular Therapy and Prevention. 2017;16(4):4-10. (In Russ.)

2. Shalnova SA, Deev AD, Balanova YuA. Treatment of hypertension in patients at high risk. Monotherapy or combination? Lechaschij vrach. 2016;7:17-23. (In Russ.)

3. Boytsov SA, Balanova YuA, Shalnova SA, et al. Arterial hypertension among individuals of 25-64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;14(4):4-14. (In Russ.)

4. Balanova YuA, Kontsevaya AV, Myrzamatova AO, et al. Economic Burden of Hypertension in the Russian Federation. Rational Pharmacotherapy in Cardiology. 2020;16(3):415-23. (In Russ.)

5. Balanova YuA, Shalnova SA, Imaeva AE, et al. Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study). Rational Pharmacotherapy in Cardiology. 2019;15(4):450-66. (In Russ.)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3